22 January 2010 | The sale of weight loss drug sibutramine is set to be suspended across the European Union because of an increased risk of cardiovascular events, following a decision by its drug regulator.
19 January 2010 | Counterfeit versions of an over-the-counter weight loss drug have been revealed by United States authorities which may have been harmful to some users.
18 January 2010 | Australia's drug regulator has rejected claims that it had called for obesity drug sibutramine to no longer be prescribed. 1 comment
24 November 2009 | Australia's drug regulator will review new evidence that links a prescription obesity drug to increases in cardiovascular events, following similar moves in the United States and Europe.